메뉴 건너뛰기




Volumn 45, Issue 2, 2006, Pages 120-123

Outcome of pregnancy in patients with systemic lupus erythematosus

Author keywords

Outcome; Pregnancy; Systemic lupus erythematosus

Indexed keywords

ADOLESCENT; ADULT; APGAR SCORE; ARTICLE; ATRIOVENTRICULAR BLOCK; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS OUTCOME; HUMAN; MATERNAL CARE; MORTALITY; NEWBORN CARE; PREGNANCY; PREGNANCY OUTCOME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 33745877153     PISSN: 10284559     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1028-4559(09)60208-4     Document Type: Article
Times cited : (43)

References (21)
  • 1
    • 0026329304 scopus 로고
    • Frequency of lupus flare in pregnancy: The Hopkins Lupus Pregnancy Center experience
    • Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy: The Hopkins Lupus Pregnancy Center Experience. Arthritis Rheum 1991;34:1538-45.
    • (1991) Arthritis Rheum , vol.34 , pp. 1538-1545
    • Petri, M.1    Howard, D.2    Repke, J.3
  • 2
    • 4644340818 scopus 로고    scopus 로고
    • Prospective study of systemic lupus erythematosus pregnancies
    • Petri M. Prospective study of systemic lupus erythematosus pregnancies. Lupus 2004;13:688-9.
    • (2004) Lupus , vol.13 , pp. 688-689
    • Petri, M.1
  • 3
    • 0024337638 scopus 로고
    • Pregnancy does not cause systemic lupus erythematosus to worsen
    • Lockshin MD. Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum 1989;32:665-70.
    • (1989) Arthritis Rheum , vol.32 , pp. 665-670
    • Lockshin, M.D.1
  • 5
  • 6
    • 3242671782 scopus 로고    scopus 로고
    • Pregnancy and autoimmune diseases
    • Gordon C. Pregnancy and autoimmune diseases. Best Pract Res Clin Rheumatol 2004;18:359-9.
    • (2004) Best Pract Res Clin Rheumatol , vol.18 , pp. 359-359
    • Gordon, C.1
  • 9
    • 18744364693 scopus 로고    scopus 로고
    • Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: A prospective controlled study
    • Brucato A, Doria A, Frassi M, Castellino G, Franceschini F, Faden D, Pisoni MP. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus 2002;11:716-21.
    • (2002) Lupus , vol.11 , pp. 716-721
    • Brucato, A.1    Doria, A.2    Frassi, M.3    Castellino, G.4    Franceschini, F.5    Faden, D.6    Pisoni, M.P.7
  • 11
    • 1242269400 scopus 로고    scopus 로고
    • Measuring systemic lupus erythematosus activity during pregnancy: Validation of the lupus activity index in pregnancy scale
    • Ruiz-Irastorza G, Khamashta MA, Gordon C. Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale. Arthritis Rheum 2004;51:78-82.
    • (2004) Arthritis Rheum , vol.51 , pp. 78-82
    • Ruiz-Irastorza, G.1    Khamashta, M.A.2    Gordon, C.3
  • 12
    • 4644239689 scopus 로고    scopus 로고
    • Disease specific problems related to drug therapy in pregnancy
    • Ostensen M. Disease specific problems related to drug therapy in pregnancy. Lupus 2004;13:746-50.
    • (2004) Lupus , vol.13 , pp. 746-750
    • Ostensen, M.1
  • 13
    • 0028113142 scopus 로고
    • Optimisation of antirheumatic drug treatment in pregnancy
    • Ostesen M. Optimisation of antirheumatic drug treatment in pregnancy. Clin Pharmacokinet 1994;27:486-503.
    • (1994) Clin Pharmacokinet , vol.27 , pp. 486-503
    • Ostesen, M.1
  • 14
    • 0035672343 scopus 로고    scopus 로고
    • Antimalarial drugs in systemic lupus erythematosus: Use in pregnancy
    • Borden MB, Parke AL. Antimalarial drugs in systemic lupus erythematosus: use in pregnancy. Drug Saf 2001;24:1055-63.
    • (2001) Drug Saf , vol.24 , pp. 1055-1063
    • Borden, M.B.1    Parke, A.L.2
  • 15
    • 0036222914 scopus 로고    scopus 로고
    • Evidence of transplacental passage of hydroxychloroquine in humans
    • Costedoat-Chalumeau N, Amoura Z, Aymard G, et al. Evidence of transplacental passage of hydroxychloroquine in humans. Arthritis Rheum 2002;46:1123-4.
    • (2002) Arthritis Rheum , vol.46 , pp. 1123-1124
    • Costedoat-Chalumeau, N.1    Amoura, Z.2    Aymard, G.3
  • 16
    • 0034990187 scopus 로고    scopus 로고
    • Hydroxychloroquine (HCQ) in lupus pregnancy: Double-blind and placebo-controlled study
    • Levy RA, Vilela VS, Cataldo MJ, et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 2001;10:401-4.
    • (2001) Lupus , vol.10 , pp. 401-404
    • Levy, R.A.1    Vilela, V.S.2    Cataldo, M.J.3
  • 17
    • 0242579534 scopus 로고    scopus 로고
    • Safety of hydroxychloroquine in pregnant patients with connective tissue diseases
    • Costedoat-Chalumeau N, Amoura Z, Duhaut P. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Arthritis Rheum 2003;48:3207-11.
    • (2003) Arthritis Rheum , vol.48 , pp. 3207-3211
    • Costedoat-Chalumeau, N.1    Amoura, Z.2    Duhaut, P.3
  • 19
    • 0032846821 scopus 로고    scopus 로고
    • Maternal corticosteroid use and risk of selected congenital anomalies
    • Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet 1999; 86:242-4.
    • (1999) Am J Med Genet , vol.86 , pp. 242-244
    • Carmichael, S.L.1    Shaw, G.M.2
  • 21
    • 0037297707 scopus 로고    scopus 로고
    • Immunosuppressive drug use in pregnancy
    • Petri M. Immunosuppressive drug use in pregnancy. Autoimmunity 2003;36:51-6.
    • (2003) Autoimmunity , vol.36 , pp. 51-56
    • Petri, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.